
TSE:DCBO
This summary was created by AI, based on 2 opinions in the last 12 months.
Docebo (DCBO-T) is recognized as a leading software solution with strong cash flow generation, which highlights its potential for takeout at current valuation levels. However, there are significant concerns about its competitive positioning, particularly regarding the presence of dominant industry players and the lack of considerable barriers to entry. Experts indicate that Docebo may be at risk of disruption, especially in the rapidly evolving AI landscape, implying that it is not as essential or 'sticky' as some competitors. Given these factors, while the current valuation may suggest a price target of up to $74, the crowded market could complicate its growth trajectory.
EPS of 28c beat estimates of 24c; revenue of $57M beat estimates of $56.1M. EBITDA of $9.5M beat estimates by 3%. But guidance came in light at $57M, vs estimates of $58.7M. Expected F/x headwinds really hurt guidance. Sales rose 16%. EPS more than tripled year over year. Cash is $82M. At the guidance level, growth is expected at 11%. The stock's reaction is very harsh, and probably more than overdone, but it is that type of market these days. Investors are worried about a lot of things, and a miss is extrapolated to mean that everything is turning. This is not likely the case here, BUT....The stock is at 26X earnings and with its new expected growth rate is could be viewed on the expensive side. We think a buy opportunity is going to set up here, but we would view it more as a HOLD until the current market angst settles down a bit.
Unlock Premium - Try 5i Free
EPS of $0.365 beat estimates of $0.311 and revenues of $75.0M beat estimates of $73.218M. Sales grew 19% driven by higher subscription revenue and customer retention. Adjusted EBITDA margins expanded from 9.7% for the same period in the prior year to 15.7%. Management noted advancements in its platform and scaling of its international operations as key drivers for sustainable growth. Its valuation is not cheap, trading at 39X forward earnings, but growth rates are good, and it is expecting to continue expanding its margins. We feel these were good results.
Unlock Premium - Try 5i Free
Its recent earnings beat estimates, but revenue guidance of 17% to 18.5% was slightly below consensus estimates. Management noted weakness in its small and medium-sized business customers, but strength in its government and enterprise customers. One of the main remarks from its press release that concerned investors was an expectation for continued macro-economic headwinds to affect its SMB and lower mid-market customers, as well as a seven-figure negative impact on its ARR base resulting from a large enterprise customer terminating its agreement. In the earnings call, management reaffirmed that it is seeing pressure in its SMB segment over the past few months, but management expects it to diffuse over time.
The flip side to this issue is that management is seeing strong growth in its enterprise and government segment. It is still waiting on its FedRAMP certification, but it is expected to boost the company's government segment in 2025, and potentially somewhat this year.
It is not that cheap at 32X forward earnings, but certainly cheaper than previously. It continues to generate free cash flow, buy back shares, and improve its margins. Fundamentally, its metrics look good, but the churn in SMB customers is concerning investors, but we feel its foray into the enterprise and government sectors can help lift its guidance over the long-term.
Unlock Premium - Try 5i Free
It is a Canadian company that does online training with add-on new clients. There is a breakout to the upside on volume. This is after basing most of the year after declining from around $92 to $23. Buy 10 Hold 1 Sell 0
He doesn't own any of his top picks but is planning to buy 2 or 3, probably 3 within the next couple of weeks.
Billy Kawasaki’s Insights - Billy’s most-liked answers from 5i Research. The price for the secondary offer was set recently but the offer was previously announced. The growth potential is positive and recent acquisitions have been good. Volatility is expected with a large stock sale. Unlock Premium - Try 5i Free
Docebo is a Canadian stock, trading under the symbol DCBO.TO (previously DCBO-T on Stockchase) on the Toronto Stock Exchange (DCBO-CT). It is usually referred to as TSX:DCBO or DCBO.TO
In the last year, 2 stock analysts published opinions about DCBO.TO (previously DCBO-T on Stockchase). 0 analysts recommended to BUY the stock. 2 analysts recommended to SELL the stock. The latest stock analyst recommendation is WATCH. Read the latest stock experts' ratings for Docebo.
Docebo was recommended as a Top Pick by Kim Bolton on 2020-10-22. Read the latest stock experts ratings for Docebo.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for help on deciding if you should buy, sell or hold the stock.
2 stock analysts on Stockchase covered Docebo in the last year. It is a trending stock that is worth watching.
On 2026-05-29, Docebo (DCBO.TO) stock closed at a price of $24.77.
Software solutions. Potential takeout at these levels. Does generate good cashflow, but his concern is that it may not have very big barriers to entry. Moat's not as big as you think, and that's reflected in the valuation. Could be more prone to AI disruption, not as sticky as some of the CSU companies.